AR004689A1 - Derivados del acido piridazinacetico y del acido tiadiazinacetico, procedimiento para prepararlos, preparaciones farmaceuticas que los contienen yprocedimiento para preparar estas preparaciones farmaceuticas. - Google Patents

Derivados del acido piridazinacetico y del acido tiadiazinacetico, procedimiento para prepararlos, preparaciones farmaceuticas que los contienen yprocedimiento para preparar estas preparaciones farmaceuticas.

Info

Publication number
AR004689A1
AR004689A1 ARP960104655A AR10465596A AR004689A1 AR 004689 A1 AR004689 A1 AR 004689A1 AR P960104655 A ARP960104655 A AR P960104655A AR 10465596 A AR10465596 A AR 10465596A AR 004689 A1 AR004689 A1 AR 004689A1
Authority
AR
Argentina
Prior art keywords
acid
prepare
procedure
pharmaceutical preparations
derivatives
Prior art date
Application number
ARP960104655A
Other languages
English (en)
Original Assignee
Merck Patent Ges Mit Beschränkter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Ges Mit Beschränkter Haftung filed Critical Merck Patent Ges Mit Beschränkter Haftung
Publication of AR004689A1 publication Critical patent/AR004689A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Derivados del ácido piridazinacético y del ácido tiadiazinacético, por responder a la fórmula I, en la que Y representa -C(R4R4)-C(R4R4)-,-CR4=CR4- o-C(R4R4)-S- R1 representa Het, Ar, R3 o R4, R2 representa Ar o un grupo no sustituído, o bien mono o disustituido en el fenilo con A,R3,OR4, NH2, NHA, NA2, NO2, CN, Hal, NHCOR4, NHSO2R4, COOR4, COR4,CONHSO2R6,O(CH2)nR3, OPh, O(CH2)n OR4 o S(O)mR4, o bien un grupo no sustituído.
ARP960104655A 1995-10-09 1996-09-10 Derivados del acido piridazinacetico y del acido tiadiazinacetico, procedimiento para prepararlos, preparaciones farmaceuticas que los contienen yprocedimiento para preparar estas preparaciones farmaceuticas. AR004689A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19537548A DE19537548A1 (de) 1995-10-09 1995-10-09 Endothelin-Rezeptor-Antagonisten

Publications (1)

Publication Number Publication Date
AR004689A1 true AR004689A1 (es) 1999-03-10

Family

ID=7774384

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960104655A AR004689A1 (es) 1995-10-09 1996-09-10 Derivados del acido piridazinacetico y del acido tiadiazinacetico, procedimiento para prepararlos, preparaciones farmaceuticas que los contienen yprocedimiento para preparar estas preparaciones farmaceuticas.

Country Status (16)

Country Link
US (1) US5883090A (es)
EP (1) EP0796250A1 (es)
JP (1) JPH10511118A (es)
CN (1) CN1168137A (es)
AR (1) AR004689A1 (es)
AU (1) AU7211996A (es)
BR (1) BR9606668A (es)
CA (1) CA2207243A1 (es)
CZ (1) CZ176897A3 (es)
DE (1) DE19537548A1 (es)
HU (1) HUP9801879A3 (es)
NO (1) NO972612L (es)
PL (1) PL320638A1 (es)
SK (1) SK73597A3 (es)
WO (1) WO1997013758A1 (es)
ZA (1) ZA968483B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187920B1 (en) * 1998-03-26 2001-02-13 Sumitomo Chemical Co., Ltd. Pyridazinone derivatives
US6670362B2 (en) * 2000-09-20 2003-12-30 Pfizer Inc. Pyridazine endothelin antagonists
GB0023074D0 (en) * 2000-09-20 2000-11-01 Pfizer Ltd Pyridazines
US6996060B1 (en) 2001-03-20 2006-02-07 Arraycomm, Inc. Closing a communications stream between terminals of a communications system
US7339906B1 (en) * 2001-03-20 2008-03-04 Arraycomm, Llc Opening a communications stream between a user terminal and a base station
DE10155076A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen
CA2577782A1 (en) * 2004-08-23 2006-03-02 Wyeth Pyrrolo-naphthyl acids as pai-1 inhibitors
BRPI0514544A (pt) 2004-08-23 2008-06-17 Wyeth Corp ácidos de oxazol-naftila como moduladores de inibidor tipo-1 de ativador de plasminogênio (pai-1)
JP2008510816A (ja) 2004-08-23 2008-04-10 ワイス チアゾロ−ナフチル酸
CN109867613B (zh) * 2017-12-01 2021-08-17 中国科学院大连化学物理研究所 一种多取代苯甲酸及其合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2832780A (en) * 1955-09-14 1958-04-29 Warner Lambert Pharmaceutical Hydrazides of pyridazonyl-substituted alkanoic acids
BR8108745A (pt) * 1980-08-07 1982-07-06 Diamond Shamrock Corp Difenilpiridazinonas herbicidas e reguladores do crescimento da planta
RO117847B1 (ro) * 1991-11-05 2002-08-30 Smithkline Beecham Corp Derivati de indan, procedeu de preparare, compozitie farmaceutica care ii contine si metoda de tratament
ZA939516B (en) * 1992-12-22 1994-06-06 Smithkline Beecham Corp Endothelin receptor antagonists
EP0617001B1 (en) * 1993-03-19 2000-01-26 Merck & Co. Inc. Phenoxyphenylacetic acid derivatives
DE4339868A1 (de) * 1993-11-23 1995-05-24 Merck Patent Gmbh Imidazopyridazine
TW282456B (es) * 1994-03-10 1996-08-01 Fujisawa Yakusin Kogyo Kk

Also Published As

Publication number Publication date
ZA968483B (en) 1997-05-20
HUP9801879A3 (en) 1999-07-28
CA2207243A1 (en) 1997-04-17
CZ176897A3 (en) 1997-10-15
CN1168137A (zh) 1997-12-17
WO1997013758A1 (de) 1997-04-17
SK73597A3 (en) 1998-05-06
NO972612D0 (no) 1997-06-06
MX9704262A (es) 1997-09-30
JPH10511118A (ja) 1998-10-27
HUP9801879A2 (hu) 1999-06-28
PL320638A1 (en) 1997-10-13
DE19537548A1 (de) 1997-04-10
EP0796250A1 (de) 1997-09-24
BR9606668A (pt) 1997-09-30
NO972612L (no) 1997-08-08
US5883090A (en) 1999-03-16
AU7211996A (en) 1997-04-30

Similar Documents

Publication Publication Date Title
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
BR9806296A (pt) Derivados de ácido sulfìnico e sua preparação e uso
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
TR200002616T2 (tr) Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
MX9202934A (es) Derivados de carbostirilo y composicion farmaceutica que los contiene.
TR199700660T1 (xx) Yeni farnezil transferaz �nleyiciler.
AR004689A1 (es) Derivados del acido piridazinacetico y del acido tiadiazinacetico, procedimiento para prepararlos, preparaciones farmaceuticas que los contienen yprocedimiento para preparar estas preparaciones farmaceuticas.
MX9203126A (es) Derivados de sulfonilurea y composiciones farmaceuticas que los contienen.
PT93213A (pt) Processo para a preparacao de derivados de n-fenilbenzamida com accao anti-ulcerosa e anti-alergica e de composicoes farmaceuticas que os contem
MX9303933A (es) Compuestos intermedios sinteticos novedosos y procedimiento para la preparacion de los derivados de los aminoacidos.
ATE84043T1 (de) Aminosaeurederivate.
AR012601A1 (es) Derivados de amidina, formulaciones farmaceuticas que los contiene, uso de dichos derivados en la preparacion de medicamentos y proceso para lapreparacion de dichos derivados
CO4650030A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, proceso para su preparacion y producto farmaceutico que los contiene
MX9203613A (es) Derivados de adenosina y composiciones farmaceuticas que los contienen.
AR005549A1 (es) Derivados de la 1-pirazol-3-iletil-4-indol-3-ilpiperidina, un procedimiento para prepararlos, medicamentos y preparaciones farmaceuticas que los contienen,un procedimiento para preparar las preparaciones farmaceuticas y empleo de los mismos para la preparacion de medicamentos.
AR012602A1 (es) Derivados de amidina, formulacion farmaceutica, uso de dichos derivados para la fabricacion de medicamentos y proceso para la preparacion de dichosderivados
ATE28188T1 (de) Antikonvulsive mittel.
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
MX9203367A (es) Benzamidas, sus sales y composiciones farmaceuticas que las contienen.
ATE57526T1 (de) P-acylaminobenzamide.
AR240835A2 (es) Procedimiento para la preparacion de nuevos derivados de gonadoliberina que contienen un grupo beta-aspartilo
BR9915589A (pt) Uso de derivados de azabicicloalcano n-substituìdo
HUP9904676A2 (hu) 1-(3-Aminoindazol-5-il)-3-fenilmetil-ciklusos karbamidok és HIV proteáz inhibitorként való alkalmazásuk
FR2580636B1 (fr) Nouveaux derives acryliques de l'uree